Tag: instituional corruption and psychiatry
A Guide to Long-Acting Neuroleptics: Education or Promotion?
The National Council for Behavioral Health has released a new pamphlet titled “Guide to Long-Acting Medications for Providers and Organizations.” By downplaying some aspects of the available science, the pamphlet implicitly acts as a promotional tool for the pharmaceutical industry.
Latest Antidepressant a Case Study in Institutional Corruption
A new study tracks the approval of the latest antidepressant, vortioxetine, by the Federal Drug Administration (FDA) and the European Medicines Agency (EMA). The...